Detalhe da pesquisa
1.
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Nature
; 596(7870): 126-132, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290408
2.
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Nature
; 598(7881): E1, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34608287
3.
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
N Engl J Med
; 378(21): 1976-1986, 2018 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29658848
4.
Combination immunotherapy strategies for glioblastoma.
J Neurooncol
; 151(3): 375-391, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33611705
5.
Evaluating T-cell cross-reactivity between tumors and immune-related adverse events with TCR sequencing: pitfalls in interpretations of functional relevance.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34230111
6.
Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma.
Oncoimmunology
; 10(1): 1940673, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290904
7.
Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial.
Nat Med
; 27(11): 1910-1920, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750557
8.
A T Cell Receptor Sequencing-Based Assay Identifies Cross-Reactive Recall CD8+ T Cell Clonotypes Against Autologous HIV-1 Epitope Variants.
Front Immunol
; 11: 591, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32318072
9.
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer.
J Immunother Cancer
; 8(2)2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929052
10.
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung Cancer.
Clin Cancer Res
; 26(6): 1327-1337, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31754049
11.
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.
J Immunother Cancer
; 7(1): 63, 2019 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30841906
12.
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.
J Immunother Cancer
; 7(1): 40, 2019 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30744692
13.
The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity.
Cancer Immunol Res
; 6(8): 888-899, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29895573